PER 2.86% 6.8¢ percheron therapeutics limited

Ann: ANP Updates on US Regulatory Plans for ATL1102 in DMD, page-115

  1. 1,703 Posts.
    lightbulb Created with Sketch. 605
    I’d think I’d be a bit disappointed if management “caved” to nervous nellies. If you believe the investment thesis then turn off the computer & await the science to drive the SP. That said - of some concern is the fact that management seemingly “didn’t get it right the first time” . In a similar vein the communication was pretty ham fisted which raises its own questions too. Let’s hope they get their A team into the game when it comes to deal making & assessing the financing alternatives.
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.